Table of Contents 1 Non-Small Cell Lung Cancer Therapeutics Market Overview 1.1 Product Overview and Scope of Non-Small Cell Lung Cancer Therapeutics 1.2 Classification of Non-Small Cell Lung Cancer Therapeutics by Types 1.2.1 Global Non-Small Cell Lung Cancer Therapeutics Revenue Comparison by Types (2017-2023) 1.2.2 Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Types in 2017 1.2.3 Biologics 1.2.4 Small molecules 1.3 Global Non-Small Cell Lung Cancer Therapeutics Market by Application 1.3.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Hospital 1.3.3 Clinic 1.4 Global Non-Small Cell Lung Cancer Therapeutics Market by Regions 1.4.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Small Cell Lung Cancer Therapeutics Status and Prospect (2013-2023) 1.5 Global Market Size of Non-Small Cell Lung Cancer Therapeutics (2013-2023) 2 Manufacturers Profiles 2.1 GlaxoSmithKline 2.1.1 Business Overview 2.1.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 GlaxoSmithKline Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 2.2 Novartis 2.2.1 Business Overview 2.2.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Novartis Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 2.3 AstraZeneca 2.3.1 Business Overview 2.3.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 AstraZeneca Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 2.4 Roche 2.4.1 Business Overview 2.4.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Roche Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 2.5 Bristol-Myers Squibb 2.5.1 Business Overview 2.5.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Bristol-Myers Squibb Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 2.6 Pfizer 2.6.1 Business Overview 2.6.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Pfizer Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 2.7 Eli Lilly 2.7.1 Business Overview 2.7.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Eli Lilly Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 2.8 Sanofi 2.8.1 Business Overview 2.8.2 Non-Small Cell Lung Cancer Therapeutics Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Sanofi Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) 3 Global Non-Small Cell Lung Cancer Therapeutics Market Competition, by Players 3.1 Global Non-Small Cell Lung Cancer Therapeutics Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Non-Small Cell Lung Cancer Therapeutics Players Market Share 3.2.2 Top 10 Non-Small Cell Lung Cancer Therapeutics Players Market Share 3.3 Market Competition Trend 4 Global Non-Small Cell Lung Cancer Therapeutics Market Size by Regions 4.1 Global Non-Small Cell Lung Cancer Therapeutics Revenue and Market Share by Regions 4.2 North America Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 4.3 Europe Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 4.5 South America Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 5 North America Non-Small Cell Lung Cancer Therapeutics Revenue by Countries 5.1 North America Non-Small Cell Lung Cancer Therapeutics Revenue by Countries (2013-2018) 5.2 USA Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 5.3 Canada Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 5.4 Mexico Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 6 Europe Non-Small Cell Lung Cancer Therapeutics Revenue by Countries 6.1 Europe Non-Small Cell Lung Cancer Therapeutics Revenue by Countries (2013-2018) 6.2 Germany Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 6.3 UK Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 6.4 France Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 6.5 Russia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 6.6 Italy Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue by Countries 7.1 Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue by Countries (2013-2018) 7.2 China Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 7.3 Japan Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 7.4 Korea Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 7.5 India Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 8 South America Non-Small Cell Lung Cancer Therapeutics Revenue by Countries 8.1 South America Non-Small Cell Lung Cancer Therapeutics Revenue by Countries (2013-2018) 8.2 Brazil Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 8.3 Argentina Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 8.4 Colombia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Non-Small Cell Lung Cancer Therapeutics by Countries 9.1 Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue by Countries (2013-2018) 9.2 Saudi Arabia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 9.3 UAE Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 9.4 Egypt Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 9.5 Nigeria Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 9.6 South Africa Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) 10 Global Non-Small Cell Lung Cancer Therapeutics Market Segment by Type 10.1 Global Non-Small Cell Lung Cancer Therapeutics Revenue and Market Share by Type (2013-2018) 10.2 Global Non-Small Cell Lung Cancer Therapeutics Market Forecast by Type (2018-2023) 10.3 Biologics Revenue Growth Rate (2013-2023) 10.4 Small molecules Revenue Growth Rate (2013-2023) 11 Global Non-Small Cell Lung Cancer Therapeutics Market Segment by Application 11.1 Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Application (2013-2018) 11.2 Non-Small Cell Lung Cancer Therapeutics Market Forecast by Application (2018-2023) 11.3 Hospital Revenue Growth (2013-2018) 11.4 Clinic Revenue Growth (2013-2018) 12 Global Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2023) 12.1 Global Non-Small Cell Lung Cancer Therapeutics Market Size Forecast (2018-2023) 12.2 Global Non-Small Cell Lung Cancer Therapeutics Market Forecast by Regions (2018-2023) 12.3 North America Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) 12.4 Europe Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) 12.6 South America Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Non-Small Cell Lung Cancer Therapeutics Picture Table Product Specifications of Non-Small Cell Lung Cancer Therapeutics Table Global Non-Small Cell Lung Cancer Therapeutics and Revenue (Million USD) Market Split by Product Type Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Types in 2017 Figure Biologics Picture Figure Small molecules Picture Table Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Application (2013-2023) Figure Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Applications in 2017 Figure Hospital Picture Figure Clinic Picture Table Global Market Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2023) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Non-Small Cell Lung Cancer Therapeutics Type and Applications Table GlaxoSmithKline Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Non-Small Cell Lung Cancer Therapeutics Type and Applications Table Novartis Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Non-Small Cell Lung Cancer Therapeutics Type and Applications Table AstraZeneca Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Non-Small Cell Lung Cancer Therapeutics Type and Applications Table Roche Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Non-Small Cell Lung Cancer Therapeutics Type and Applications Table Bristol-Myers Squibb Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Non-Small Cell Lung Cancer Therapeutics Type and Applications Table Pfizer Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Non-Small Cell Lung Cancer Therapeutics Type and Applications Table Eli Lilly Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Non-Small Cell Lung Cancer Therapeutics Type and Applications Table Sanofi Non-Small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2016-2017) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Players (2013-2018) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Players (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Players in 2016 Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Players in 2017 Figure Global Top 5 Players Non-Small Cell Lung Cancer Therapeutics Revenue Market Share in 2017 Figure Global Top 10 Players Non-Small Cell Lung Cancer Therapeutics Revenue Market Share in 2017 Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Regions (2013-2018) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Regions (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Regions (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Regions in 2017 Figure North America Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Europe Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure South America Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Table North America Non-Small Cell Lung Cancer Therapeutics Revenue by Countries (2013-2018) Table North America Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure North America Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure North America Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries in 2017 Figure USA Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Canada Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Mexico Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Table Europe Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Countries (2013-2018) Figure Europe Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure Europe Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries in 2017 Figure Germany Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure UK Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure France Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Russia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Italy Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Table Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries in 2017 Figure China Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Japan Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Korea Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure India Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Southeast Asia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Table South America Non-Small Cell Lung Cancer Therapeutics Revenue by Countries (2013-2018) Table South America Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure South America Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure South America Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries in 2017 Figure Brazil Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Argentina Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Colombia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Table Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Countries in 2017 Figure Saudi Arabia Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure UAE Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Egypt Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure Nigeria Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Figure South Africa Non-Small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2013-2018) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) by Type (2013-2018) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Type (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Type (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Type in 2017 Table Global Non-Small Cell Lung Cancer Therapeutics Revenue Forecast by Type (2018-2023) Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share Forecast by Type (2018-2023) Figure Global Biologics Revenue Growth Rate (2013-2018) Figure Global Small molecules Revenue Growth Rate (2013-2018) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue by Application (2013-2018) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Application (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Application (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Share by Application in 2017 Table Global Non-Small Cell Lung Cancer Therapeutics Revenue Forecast by Application (2018-2023) Figure Global Non-Small Cell Lung Cancer Therapeutics Market Share Forecast by Application (2018-2023) Figure Global Hospital Revenue Growth Rate (2013-2018) Figure Global Clinic Revenue Growth Rate (2013-2018) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Non-Small Cell Lung Cancer Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Non-Small Cell Lung Cancer Therapeutics Revenue Market Share Forecast by Regions (2018-2023) Figure North America Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) Figure Europe Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) Figure Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) Figure South America Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023) Figure Middle East and Africa Non-Small Cell Lung Cancer Therapeutics Revenue Market Forecast (2018-2023)

GlaxoSmithKline Novartis AstraZeneca Roche Bristol-Myers Squibb Pfizer Eli Lilly Sanofi